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Exploring interpretations of blockchain’s value in healthcare: a multi-
stakeholder approach1 
Jahir Palas & Raluca Bunduchi 
Abstract  
Purpose – Drawing broadly from the technology frame (Davidson, 2002) and organizing 
vision perspectives (Swanson and Ramiller, 1997) which consider the business value of 
information technology as resulting from actors’ efforts to make sense of new technology, the 
study applies Ojala’s (2016) business model framework to examine how different sets of actors 
understand the value of blockchain within the healthcare sector. 
Design/methodology/approach – To include the perspective of different sets of actors, the 
research combines a systematic literature review to capture academic research, semi-structured 
interviews with blockchain experts, with an analysis of blockchain healthcare vendors.  
Findings – The study finds a high degree of congruence between the perspective of different 
actors, with key sources of blockchain value concentrated around value proposition, 
particularly enhancing privacy and security; value capture, specifically cost savings, and value 
network, mostly enhancing data accessibility and reducing intermediation. Value delivery is 
the least emphasized value creation mechanism and concerns primarily improvements in 
supply chain transparency. Minor variations between actors’ interpretations of value exist, 
mostly around the contribution of blockchain to support the value proposition and include the 
provision of social value, the creation of trust, supporting automation, and improving 
employment. 
                                                 
1 This is the authors’ manuscript version of a paper accepted for publication in Information Technology & People 
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Originality/value – Recognizing that the value of new technology is as much the result of 
actors’ interpretations, as the objective outcome of its deployment, this study takes a multi-
stakeholder perspective to examine blockchain’s business value and highlights new aspects of 
value associated with blockchain deployments. The findings include a value outcome 
framework that allows systematic comparisons between blockchain implementations across 
contexts. 
1. Introduction 
Barely 10 years old, blockchain, a new technology that emerged in 2008 to support Bitcoin, a 
digital cryptocurrency, promises to fundamentally change how organizations manage their 
contracts, transactions and records, and in doing so to create new ways for organizations to 
generate value for customers and capture back some of that value (Iansiti and Lakhani, 2017). 
A critical question to understand blockchain potential is thus: how do different actors make 
sense of this new technology and its value potential, while its key features and functionalities 
are still being developed? This study explores this question by investigating how three sets of 
key actors: academics, experts and vendors, understand the potential of blockchain technology 
to alter the value creation and capture ability of organisations within a particular sector: 
healthcare.   
Blockchain is a distributed ledger of economic transactions which is both transparent and, in 
principle, incorruptible (Tapscott and Tapscott, 2016). A growing body of work explores 
blockchain’s potential to change how organizations create and capture value (Tapscott and 
Tapscott, 2016) in a variety of contexts, starting first applications in the financial services 
sector (Buehler et al., 2015, Beck and Müller-Bloch, 2017, Taylor, 2015) and then rapidly 
moving into the supply chain (Kim and Laskowski, 2018), the third sector (Kewell et al., 2017) 
and healthcare (Mettler, 2016). 
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Such research tends to describe specific blockchain deployments which are claimed to create 
value by improving existing processes, such as Nasdaq’s plan to leverage blockchain 
technology to enhance its equity management capabilities (Pilkington, 2016), and by enabling 
new forms of transactions, such as the blockchain for good applications described in Kewell 
(2017). More recent research tends to emphasize the potential disruptive implications of 
blockchain, including supporting entirely new types of business models (Morkunas et al., 
2019), enabling new forms of governance (Beck et al, 2018), and generating new forms of 
economic institutions (Allen et al., 2020). Such studies suggest blockchain may be creating 
value not only by improving existing business processes, but by radically changing how 
business works. There is however little effort to systematically explore the bases behind these 
value claims, and even less effort to consider whether different actors within the blockchain 
community may hold different value expectations. Faced with new technology, people form 
expectations about what the new technology entails, what value it provides and how it may 
change existing practices (Orlikowski and Gash, 1994). These expectations are critical, as they 
influence actors’ actions in the real world (Davidson and Pai, 2004, Orlikowski and Gash, 
1994), playing a critical role in explaining, for example, the diffusion of a new technology, 
such as blockchain. With the possible exception of the financial services sector, blockchain is 
still in the early stages of adoption (Du et al., 2019; Queiroz and Wamba, 2019; Morkunas et 
al., 2019), with very few commercial grade applications (Hughes et al., 2019). There are thus 
very few studies of large-scale implementations of blockchain, meaning there is very limited 
evidence on the actual value of blockchain, and incomplete understanding of its overall costs 
and benefits (Pan et al., 2020). Under these conditions, blockchain adoption is likely to be 
driven by the positive perceptions people have concerning its benefits, which drive investment 
in commercial applications and lower resistance by creating positive cultural and social 
attitudes to influence the transition towards blockchain applications (Hughes et al., 2019). For 
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example, research on blockchain adoption in supply chain finds the expectations of supply 
chain professions concerning blockchain performance (Queiroz and Wamba, 2019) and 
benefits (Wang et al., 2019) as the most important factor shaping its diffusion in the supply 
chain. Different actors may however form different expectations about a new technology, 
developing different visions of what the technology involves, what organizational practices it 
affects, and what business value it creates (Swanson and Ramiller, 1997). Congruence amongst 
the visions that relevant groups of actors form about a new technology explains was found to 
explain both its adoption and use within organizations (Olesen, 2014), and its diffusion across 
organizations (Currie, 2004). Therefore, understanding the degree of alignment between the 
value expectations of different categories of blockchain actors is important to explain the 
adoption and diffusion of blockchain.  
To explore the congruence between the expectations of technology value within the blockchain 
community, the study explores the perspective of three key stakeholders: academics, experts 
and vendors, within a particular sector: healthcare. Healthcare industry has long been a fruitful 
field to study the adoption and use of new forms of information technologies (IT) (Chiasson 
and Davidson, 2005). Spending on healthcare represents a large share of public expenditure, 
ranging from 17.2% of the Gross Domestic Product in US to 5.4% in Mexico (OECD, 2017), 
making healthcare a key area of national economic activity. Besides its economic significance, 
healthcare industry is also critical due to the sensitive nature of goods and services offered 
(Babitsch et al., 2012). Moreover, the multitude of actors and the combination of public and 
private interests that characterise healthcare sectors (Currie and Guah, 2007) generate 
complexities that allow a more fruitful examination of how stakeholders’ interpretations shape 
technology adoption and use (Bunduchi et al., 2019).  
The paper is organized as follows: the next section discusses the business model as a framework 
to examine the business value of information technology (IT) and examines evidence from 
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current blockchain research that supports the application of the framework to study blockchain. 
Existing research considering how different categories of actors make sense of new technology 
is discussed next. The methodology section describes the research design that incorporates 
three strands to reflect the perspective of three sets of actors: a systematic literature review, 
expert interviewing and an analysis of key vendors’ product information. The results of these 
studies are presented in the findings section, and then discussed in terms of contributions to 
theory and practice in the discussion section. The conclusion section clarifies the limitations of 
the studies and future avenues of research.  
2. New technology and business value: business model and blockchain 
Creating business value through IT has been a major research topic in information systems 
research for over three decades (Schryen, 2013). Business value is generally conceptualized as 
an outcome of investment in and deployment of IT and concerns the efficiency and strategic 
impacts of technology use on organizational performance (Melville et al., 2004). Two 
complementary perspectives have driven most research on IT and value creation (Oh and 
Pinsonneault, 2007): the resource centered approach which argues that IT is a strategic resource 
which creates value either by itself (Brynjolfsson and Hitt, 1996) or through combination with 
other complementary resources (Mata et al., 1995), and the contingency perspective which 
argues that value is created as a result of a good fit between IT strategy and business strategy 
(Henderson and Venkatraman, 1999). During the last two decades, significant advancements 
in IT combined with pervasive digitalization have however triggered fundamental changes in 
how organizations conduct economic exchanges within and across their boundaries 
(Mendelson, 2000), and develop strategies to create value (Bharadwaj et al., 2013), and in the 
nature of products and services embodied in their value propositions (Nambisan, 2013, Yoo et 
al., 2012). These changes have highlighted the limitations of traditional strategic management 
theories such as resource-based view to explain the business value of IT (Bharadwaj et al., 
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2013, Kohli and Grover, 2008, Yoo et al., 2012), prompting researchers to suggest new 
approaches, such as the business model framework, as more suitable to examine the digitally 
enabled changes in the value creation potential of IT (Amit and Zott, 2001, Hedman and 
Kalling, 2003). 
While many definitions of business model exist, the concept generally encapsulates the logic 
of how a business works (Magretta, 2002, Teece, 2010) depicting “the content, structure and 
governance of transactions” (Amit and Zott,(2001), p. 511) that allow an organization to create 
and capture value for all its exchange partners (Zott and Amit, 2007). The business model 
incorporates the overall value network within which an organisation and its activities are 
embedded, and on which the organisation relies on to create and deliver its value propositions 
to customers and to capture some of that value back (Al-Debei et al., 2008, Al-Debei and 
Avison, 2010, Teece, 2010, Osterwalder et al., 2005). The business model concept thus 
transcends the boundaries of an organisation to encompass its entire network. By considering 
the way in which the organisation interacts with others to create and capture value (Zott et al., 
2011), the business model concept has been useful to explore not only how individual 
organisations (Chesbrough and Rosenbloom, 2002), but also entire industries (Johnson and 
Suskewicz, 2009) unlock the value potential of new technologies to create and capture value.  
There are many approaches to map the constituent parts of the business model (Osterwalder et 
al., 2005, Chesbrough, 2007, Morris et al., 2005). In an influential review of business model 
research, Zott et al. (2011) distinguish as core to the logic of business model the organisation’s 
revenues and cost, its value proposition and the mechanisms through which value creation and 
capture works, i.e. its system of activities. While Zott et al. (2011) do not propose an 
overarching business model framework to add to existing research, the elements they identify 
as core in their review map onto Ojala’s (2016) business model framework. This framework 
distinguishes between four components: value proposition (what value is created for 
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stakeholders), value capture (the revenues generated and costs incurred by the organisation), 
and the value network and value delivery (the system of activities within and outside the 
organisation) (a similar although not identical distinction is made earlier by Al-Debei and 
Avison (2010) between value proposition, architecture, network and finance). While the value 
creation and capture components explain what value the organisation generates for others and 
for itself, the value delivery and network components explain how this value is generated 
through interactions within and outside the organisation (see figure 1).  
HOW IS THIS VALUE GENERATED?
(system of organisational activities)
WHAT VALUE IS GENERATED?
(outcome of organisational activities)
VALUE CAPTURE
What is the value captured by the 
organisation?
VALUE NETWORK
How do the interactions between the 
organisation and its external partners 
enable the organisation to create and 
capture value? 
VALUE DELIVERY
How do the processes involving 
organisational activities and resources 
enable the organisation to create and 
capture value?
VALUE PROPOSITION
What is the value the organisation 
creates for its stakeholders?
THE VALUE THAT AN 
ORGANISATION GENERATES
 
Figure 1. Four value-components framework (adapted from Ojala, 2019) 
 
Seeing its alignment with the broad understanding in business model research (Zott et al., 2011) 
we employ here Ojala’s (2016) classification of business model components. We however 
depart from their approach to employ the concept to explore the impact of technology on a 
particular organisation. Central to the business model framework is the concept of value: how 
value is created and how is it captured (Zott et al., 2011). While the impact of blockchain may 
(and will) be different on different healthcare organisations following different business 
models, we use the four value components as a lens to examine the way in which the application 
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of blockchain in healthcare influences in general how value is created and captured within this 
sector. We are examining here the expectations that actors form about how the use of 
blockchain will affect what value the organisation generates (represented at the top in figure 1) 
and how this value is generated in the organisation (represented at the bottom in figure 1). 
The value proposition encapsulates the relationship between the product/service an 
organisation offers and existing technologies (Adomavicius et al., 2008, Arthur, 2009), and the 
product/service’s value generation mechanisms for all stakeholders (Al-Debei and Avison, 
2010, Amit and Zott, 2001, Osterwalder and Pigneur, 2010, Osterwalder et al., 2005). Some 
recent research suggests that blockchain use may significantly alter the value proposition 
organisations offer to their customers by opening up new customers markets and offering them 
access to products and services that were previously unavailable (Morkunas et al., 2019). 
However, studies examining current blockchain deployment suggest that most such changes in 
value proposition involve incremental improvements, such as faster service delivery, rather 
than radical changes. Current deployments to transform the provision of public services 
demonstrate how blockchain can improve the value proposition government organisations 
offers to their stakeholders. For example, Sweden deployed blockchain to improve land registry 
services, enabling a wide range of stakeholders such as traders of land, government authorities 
and banks to instantaneously interact and track progress of land contracts and settlements 
(Chavez-Dreyfuss, 2016). A similar initiative is underway in Georgia (Underwood, 2016). 
Other examples include the use of blockchain to speed up the recording and transaction of trade 
licencing, vehicle registration, marriage and birth certificates, student loans, educational 
certificates and government’s welfare benefits (Ølnes et al., 2017).  
Within healthcare, existing research finds that blockchain creates value for patients primarily 
through improving existing services, for example by facilitating access to patient data by 
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facilitating the healthcare management process involved in granting data access permissions 
(Kumar, 2004), by enhancing data privacy and security through not only preventing 
unauthorized access (Kshetri, 2017) but also ensuring ownership over tamper-proof personal 
data (Zyskind and Nathan, 2015), and by reducing (although not eliminating) the chances of 
counterfeiting (Crosby et al., 2016, Engelhardt, 2017, Mackey and Nayyar, 2017, Hoy, 2017). 
The value network depicts the key internal and external stakeholders, such as designers and 
R&D personnel, and customers, suppliers, investors and other partners, which engage in 
transactions with the organisation (Hamalainen and Ojala, 2017). The extent of the 
organisation’s relationship with its key stakeholders explains the degree to which the 
organisation depends on others for generating value (Al-Debei and Avison, 2010, Osterwalder 
and Pigneur, 2010, Osterwalder et al., 2005, Zott et al., 2011). Existing research suggest that 
the most significant benefit of blockchain consists in the reduction of transaction costs (Allen 
et al., 2020), arguably leading to the emergence of new forms of institutions to govern 
exchanges amongst internal and external actors (Beck et al., 2018). These institutional 
innovations involve radical changes in how organizations coordinate interactions with network 
partners, often through supporting disintermediation, and more fluid relationships amongst 
supply chain actors (Hughes et al., 2019; Morkunas et al., 2019; Wang et al., 2019). Other 
studies emphasise the potential improvements that blockchain can bring to these interactions, 
mostly through improving trust between supply chain actors (Hugest et al., 2019), thus 
encouraging better collaboration and resilience in the supply chain (Dubey et al., forthcoming). 
Some other research draws attention to the possibly of re-intermediation rather than 
disintermediation, arguing that blockchain deployments increase the number of actors in the 
supply chain (Tonniseen and Teuteberg, 2020). 
Current deployments in the financial services by diverse organisations such as Santander, 
Goldman Sachs, Royal Bank of Scotland, Citibank, Visa, and MasterCard demonstrate how 
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blockchain may enact these radical changes in the nature of the relationships with the internal 
and external actors that form an organisation’s value network. For example, blockchain brings 
in new internal stakeholders by enabling the connection of new intra-organisational processes, 
while also altering the nature of existing relationships through enabling richer integration of 
diverse functionalities through facilitating smooth and secure data sharing (Xu et al., 2016). 
Other studies highlight the incremental changes that blockchain deployment can bring to how 
organisations interact with their network to create and capture value. Blockchain deployments 
in the retailing sector for example illustrate how the technology can improve the quality of 
relationships with existing suppliers by, for example, facilitating detailed and accurate tracking 
of goods and reducing the possibility of counterfeit products (Crosby et al., 2016), although 
not eliminating it entirely. For example, Walmart is piloting blockchain to track the origin and 
movements of pork in China, while Alibaba is implementing a private blockchain network with 
the aim to reduce counterfeit products in its supply chain. 
Within healthcare, existing studies find blockchain enables democratic access to patients’ 
healthcare data (Atzori, 2015, Underwood, 2016) and empowers patients to exercise 
individualized control over their health data (Tapscott and Tapscott, 2016, Zyskind and Nathan, 
2015), thus reducing intermediation. More widely, blockchain is found to strengthen 
collaboration amongst dispersed healthcare system actors (Swan, 2015), thus eliminating many 
of the data sharing challenges characterising the health industry (Kumar, 2004). 
Value delivery explains how value is exchanged with the organisation’s stakeholders (Al-
Debei and Avison, 2010, Osterwalder and Pigneur, 2010, Teece, 2010), and includes the 
channels of distribution, the key activities and resources the organisation exploits to deliver 
this value (Osterwalder and Pigneur, 2010, Osterwalder et al., 2005). Thus, while value 
network encompasses the organisation’s stakeholders and the nature of their relationship (e.g. 
the degree of integration, and the level of trust), value delivery concerns the processes through 
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which the organisation transfers value to these stakeholders. These processes include the nature 
of activities through which this transfer takes place (e.g. how easy are these activities 
undertaken, their accuracy and continuity), and the resources used to support such value 
transfer (e.g. the use of certain technologies) (Hamalainen and Ojala, 2017).  
Changes in value delivery commonly emphasised in blockchain research concern mostly 
improvements in existing processes related to faster, cheaper (Morkunas et al., 2019) and more 
transparent transactions (Dubey et al., forthcoming; Tonnisen and Teuteberg, 2020) facilitated 
by blockchain’s ability to automate, streamline and increase the speed of existing processes 
(Hughes et al., 2019; Wang et al., 2019). For example, the deployment of blockchain-based 
“smart contracts”, algorithms which automatically execute predefined actions when a set of 
conditions are met, are claimed to speed up business processes execution (Milani et al., 2016). 
Such findings suggesting incremental improvements in value delivery are replicated in 
empirical studies of blockchain deployments. For instance, blockchain is claimed to have 
significantly improved the UK welfare payment processes by making pay-outs more 
customizable, auditable and secure(Maupin, 2017).  
In healthcare, blockchain is found to improve efficient resource management (Tapscott and 
Tapscott, 2016) primarily through the automation of data recording and validating processes 
(Tapscott and Tapscott, 2016, Ølnes et al., 2017), and through reducing the possibility of 
hacking and preventing unauthorized access to data (Cai and Zhu, 2016). Research also finds 
that blockchain implementation are generally associated with the establishment of structured 
data platform and wider process automation (Cai and Zhu, 2016), which lead to improvements 
in transparency, accuracy (Tapscott and Tapscott, 2016) and security (Gervais et al., 2016) of 
data records. Indirectly thus, blockchain deployments encourage organisations to improve the 
transparency, accuracy and security in their digital processes. 
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Value capture explains how an organisation makes money, i.e. how its products and services 
offered to network partners and consumers translate into financial revenue. The higher the 
bargaining power of its partners, the more of the revenues are passed onto them, and the less 
value is captured back into the organization (Zott and Amit, 2007). Some research argues that 
blockchain may radically change the value that the organization can capture by creating new 
ways of exchanging economic value among actors (Allen et al., 2020) and altering how both 
economic and social value is translated across different stakeholders (Elsden, 2019).  
Studies of current blockchain deployments however tend to find incremental changes in value 
capture, rather than radical changes, involving mostly the ability of blockchain to reduce the 
costs and time involved in managing its business. For example, in the banking sector, the Corda 
platform, jointly developed by the blockchain based startup R3 and Circa, redesigned the 
financial settlement process and in doing so significantly reduced the time and cost involved 
in reconciliation between multiple actors (Brown et al., 2016). In both equity markets and 
insurance sectors, blockchain deployments are claimed to have reduced both settlement time 
and the transaction costs, while improving service quality by preventing erroneous, redundant 
and outdated data (Milani et al., 2016).  
Existing healthcare research highlights blockchain’s ability to reduce costs and increase 
revenues for healthcare providers primarily through considering the effects on improving value 
delivery, in particular automation and better resource management to reduce costs (Tapscott 
and Tapscott, 2016), and reducing the possibility of hacking to attract more clients, resulting 
in higher revenue (Cai and Zhu, 2016), rather than considering the direct effect of blockchain 
on firms’ monetisation mechanisms. Blockchain is also seen to lower audit expenditure through 
facilitating compliance (Tapscott and Tapscott, 2016, Atzori, 2015), and even potentially to 
generate employment (Liu et al., 2017). 
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In conclusion, the business model provides a useful framework to examine how organisations 
operating within a particular industry use a new technology to change what value they create 
and capture and how they do so (see figure 1). There is growing evidence that blockchain has 
the potential to influence all four components of the business model across industries, as well 
as specifically in healthcare.  
3. Interpretations of value across multiple stakeholders: expectations, 
technology frames and organising visions  
In the context of a new technology, where there is limited knowledge of its implementation, its 
value is assessed based on the expectations that actors form about that new technology, rather 
than on their actual experience of implementing and using the technology. It is these 
expectations, rather than the evaluations of realised outcomes following technology use, that 
shape the early stages of an emerging technology diffusion (Swanson and Ramiller, 1997) by 
providing structure and legitimation to the technology discourse, attracting interest and 
fostering investment, shaping what to expect and how to prepare, and playing a central role in 
mobilizing and coordinating resources to develop and adopt the new technology (Borup et al., 
2006). Such expectations are important not only for the technology developers themselves, but 
also for other relevant group of actors including researchers, government policy, industry 
networks and organisations (Borup et al., 2006).  
Our approach to highlight the role that actors’ expectations play in shaping the pattern of 
technology adoption (at organisational level) and diffusion (at industry level) is congruent with 
socialized theoretical approaches that have been developed and/or employed by the information 
systems community to examine the role that individual actions and practices play in shaping 
the adoption and use of IT in organisations. Actor network theory (Latour, 1987), social 
construction of technology (Pinch and Bijker, 1984) and social shaping of technology 
14 
 
(Williams and Edge, 1996), structuration theory (Giddens, 1984), technology frames 
(Orlikowski and Gash, 1994) and organizing vision (Swanson and Ramiller, 1997), and more 
recently sociomateriality (Orlikowski and Scott, 2008) are examples of such approaches. They 
all draw the attention to the role that the social – rather than the economic or technical – plays 
in shaping the adoption and use of new technologies, viewing technology as socially 
constructed through human (SCOT) and non-human (ANT) action, and examining how varied 
actors’ interpretation, expectations, interests and conflicts shape the production (SCOT, ANT), 
use (structuration, practice lens, technological frames, sociomateriality) and diffusion 
(organizing vision) of technology.  
To understand how actors form these expectations and interpretations of a new technology, and 
particularly in relation to the value it generates in organizations, we draw here from the 
technology frames perspective (Orlikowski and Gash, 1994). Technology frames perspectives 
recognizes that new technologies introduced within organizations are open to different 
interpretations, with different actors framing the technology differently depending on their 
interests, power, knowledge and context, as well as on the technology material features 
themselves (Davidson, 2002, Orlikowski and Gash, 1994). A key element of these 
interpretations refers to the business value of the new technology (Davidson, 2002), or more 
widely to the rationales for which the technology is to be adopted and the criteria for measuring 
success (Orlikowski and Gash, 1994, Davidson and Pai, 2004). Within a healthcare 
organization, for example, managers may see new technologies as means of achieving 
administrative goals such as more efficient allocation of resources, while medical staff may see 
them as ways of achieving professional goals, such as improved quality of care (Bunduchi et 
al., 2015). Within organizations, lack of congruence between the interpretations of relatively 
interdependent groups of actors (generally users, designers and managers) concerning a new 
technology was found to hamper its adoption and use (Davidson, 2002, Olesen, 2014). 
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At industry level, a related concept is organising vision, defined as the interpretations that a 
new technology community form concerning the organizational application of a new 
technology (Swanson and Ramiller, 1997). A key element of organizing vision is the “business 
problematic”, reflecting the rationale for IT adoption, i.e. the value that user organizations 
extract through its use (Swanson and Ramiller, 1997). The organizing vision plays a critical 
role in interpreting the emerging technology in terms of its application to solve particular 
business problems, legitimizing the technology within a particular community, and mobilizing 
resources to generate interest and support its diffusion (Swanson and Ramiller, 1997, Kaganer 
et al., 2010). At an industry level, the relevant groups of actors involved in the interpretation 
of a new technology and the emergence of its organizing vision are more loosely connected 
than it is the case when considering technological frames within organizations. For example 
Currie (2004) examines the role that the lack of congruence between the visions developed by 
vendors, industry analysists and academic institutions played in explaining the failure of a new 
technology to diffuse across the software industry, while in healthcare Greenhalgh et al. (2012) 
documents the different interpretations developed by policy makers, technology vendors, 
researchers and academic institutions, clinicians and management consultants which hampered 
the adoption of telehealth. At industry level, congruence thus matters between the visions of 
actors loosely connected within communities of practice (Swanson and Ramiller, 1997). 
Community of practices are defined here as a set of actors with interests in a common 
technology, and whose members include vendors and users, industry associations, research and 
consultancy firms and regulatory agencies (Wang and Swanson, 2007). How these loosely 
connected actors interpret an emerging technology reflects their interests, for example, 
powerful vendors seek to develop new technology-enabled products, analysts work to generate 
hype to further their own business opportunities, and academic institutions develop new 
courses to attract students and to be seen to keep up-to-date with the latest trends (Currie, 2004). 
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While different interpretations concerning the applications of an emerging technology are 
common during its early stages and not necessarily harmful to its later adoption (Swanson and 
Ramiller, 1997), when such interpretations are too varied and thus not easily understood by 
loosely coupled members of the community, too conflicting and thus sending mixed messages 
to users concerning the benefits of the technology, and bear little resemblance to the reality, 
the adoption of the new technology becomes problematic (Currie, 2004). Persistent different 
interpretations of the same technology between actors, even when such actors are loosely 
connected,  affect its legitimation within the community, and hamper the mobilization of 
resources to support its development (Wang and Swanson, 2007). Empirical studies found that 
inconsistent visions of an emergent technology between such loosely coupled community 
actors explained why a new technology failed to diffuse (Currie, 2004, Greenhalgh et al., 2012, 
Swanson and Ramiller, 1997). Such inconsistent visions is a particular problem within the 
healthcare domain, where the groups involved have various commercial, political, professional 
and institutional allegiances, place different values on the use of technologies, and combine 
interests aligned with professional norms for clinical quality with conflicting managerial 
demands for efficiency (Currie and Guah, 2007, Greenhalgh et al., 2012). In this domain, 
existing evidence suggests that achieving coherence between multiple interpretations is 
particularly difficult, with emerging technologies often struggling to achieve consistency 
(Greenhalgh et al., 2012). 
In conclusion, the technology frames / organising vision perspective informs our analysis of 
blockchain value by highlighting that (1) in the nascent stages of a technology, expectations of 
technology value inform actors’ likelihood to adopt a technology; (2) there is rarely one single 
interpretation of a new technology in general, its business value in particular, as multiple actors 
construct multiple interpretations depending on their interests; and (3) understanding the degree 
of coherence amongst these multiple interpretations is important as it shapes the diffusion 
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patterns of that technology within an industry. To analyse the value of blockchain, we thus 
complement the business model framework with insights from the organising vision 
perspective by examining the degree of congruence amongst the expectations of three 
categories of key actors concerning the ways in which blockchain affects the four value 
dimensions (as per figure 1). 
4. Research Methodology  
The research methodology combines three sources of data to examine different stakeholders’ 
value expectations. (1) A systematic literature review of published academic research 
concerning blockchain deployment in healthcare captures the academic audience’s perspective. 
(2) Semi-structured interviews with members of the blockchain community recognized as 
experts in the field capture the perspective of blockchain experts. These experts include 
researchers and academics, technology vendors and developers, consultants and representative 
of standardization organizations who play a significant role in shaping the discourse within the 
blockchain field, for example, through acting as keynote speakers at key professional 
conferences, representing of key professional associations in the field, or being recognized as 
critical actors connecting developers and users in the field. (3) A database of firms developing 
blockchain products in the healthcare space which captures vendors’ expectations. These three 
categories are not entirely mutually exclusive. A particular individual may have published 
research on blockchain, may be a recognized expert within the community participating in key 
conferences and events, and could be employed by a technology vendor. In aggregate, however, 
academics, experts and vendors play distinct roles in shaping the discourse within an emerging 
community (see Currie, 2004). Our approach to include vendors, experts and academics, but 
not other actors such as healthcare providers, patients and regulators is due to the complexity 
and nascent stage of blockchain technology. At the time of our study, blockchain was (and still 
is) in a nascent stage, with few commercial, large-scale implementations (Hughes et al., 2019), 
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and characterised by high degree of technical complexity that obscures the potential of the 
technology to potential users (Du et al., 2019). We have thus only considered stakeholders that 
either had direct experience of the technology, and/or the understanding of the technology and 
its potential application necessary to provide an informed view. 
4.1  Systematic literature review 
The systematic review covered published academic literature in health research, IT and social 
science discipline. Its objectives were to understand and evaluate the scope of existing research; 
and to categorize and analyse published evidence on the development, implementation and 
usage reflecting academic knowledge and expectations concerning the value of blockchain in 
healthcare. The review followed (Kitchenham, 2004) structured guidelines, which includes five 
stages: identification of research, selection of studies, quality assessment, data extraction and 
data analysis.  
3.1.1 Identification of research 
A pilot search was conducted in early June, 2018 in IEEE database to identify the keywords 
that yielded more comprehensive search results. The pilot involved a few iterations to refine 
the search query resulting in the final search query included below. 
Table 1. Search query: free field-format 
(Health OR Healthcare OR Hospital* OR Clinic* OR Medic*) AND ("blockchain*" OR
"block chain*" OR "blockchain technology*" OR "blockchain technique*" OR
"blockchain framework*" OR "blockchain security*" OR "blockchain application*" OR
"blockchain application*" OR "blockchain use*" OR "blockchain ledger*" OR
"blockchain protocol*" OR "digital ledger*" OR "distributed ledger*" OR
"decentralized ledger*" OR "digitized ledger*" OR "secure ledger*" OR "public
ledger*" OR "distributed database*" OR "decentralized database*" OR "digital
database*" OR "digitized database*" OR "secure database*" OR "sequential
database*" OR "public database*" OR "distributed network*" OR "decentralized
network*" OR "secured network*" OR "chainbook*" OR "chained ledger*" OR
"chained database*" OR "chained network*" OR "verifiable ledger*" OR "verifiable
database*" OR “verifiable network*" OR “hashed ledger*" OR "hashed database*" OR
“hashed network*" OR “encrypted ledger*" OR "encrypted database*" OR “encrypted
network*" OR "merkle tree*" OR "satoshi*" OR "nakamoto*" OR "satoshi nakamoto*"
OR "peer to peer database*" OR "p2p database*" OR "blockchain implementation*"
OR "blockchain challenge*" OR "cryptocurrency*" OR "cryptography*" OR
"encryption*" OR "ethereum*" OR "ICO*" OR "mining*" OR "node*" OR "private
key*" OR "smart contracts*" OR "token*" OR "block*" OR "blocks*")
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The search query was applied in the last week of June, 2018 to 10 online databases including 
studies related to health/medical sector studies: (EMBASE, MEDLINE, Cochrane Library); IT 
(IEEE Explore); social science (ASSIA, Sociological Abstracts, ABI/INFORM); and 
multidisciplinary research (ScienceDirect, Scopus, Web of Science Core Collection). The 
MEDLINE database required a different form of search query (see Appendix 1). To capture 
relevant studies not included in these databases, two further searches were conducted, one using 
google scholar to find relevant academic thesis papers and working papers, and another hand 
search of qualifying studies’ references. The expert interviewing conducted in parallel was also 
used to identify suggestions regarding further research paper and concept notes. The initial 
search criteria did not include any language and publication year restrictions.  
3.1.2 Selection of studies 
The search results (titles, abstracts and later full text) were screened for relevance, in terms of 
whether they concern blockchain applications deployed within healthcare. The inclusion 
criteria were that the article should (1) be relevant to blockchain and healthcare sector; (2) have 
a formal or semi-formal research approach (3) evaluate blockchain’s adoption or usage or both 
in healthcare context. The exclusion criteria concerned articles that were (1) not focused on 
blockchain in healthcare context; (2) purely market-based research; (3) technical paper based 
on software designing and coding; (4) not focused on business value of blockchain; (5) not 
peer-reviewed. The PRISMA flow diagram below details the filtering procedure in each stage 
of screening, the inclusion and exclusion criteria, and the number of results.  
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Figure 2. PRISMA flow diagram 
3.1.3 Quality assessment 
The “Critical Appraisal Skills Programme” checklist was adapted for assessing the quality of 
the eligible articles (CASP, 2013). To document lack of clarity in the articles regarding any 
specific checklist item, an extra option entitled as “not clear” was added to the default options 
(“yes” and “no”). 
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3.1.4 Data extraction  
The data extracted included author(s), year of publication, country of research, income group, 
journal’s discipline, healthcare area, research design, research questions/objectives, conceptual 
or theoretical basis, the value of blockchain adoption, and major findings. Appendices 2-5 
provide key information about selected studies. 
4.2  Blockchain expert interviewing 
Expert interviewing was used to capture the perspectives of blockchain technology experts. 
Respondents were selected based on potential respondents’ experience, understanding and 
contribution to the blockchain field. Blockchain technology experts were identified through 
hand searching individuals from panel discussants in conferences (e.g. Blockchain Summit 
Conference, World Blockchain Technology Forum, Blockchain World Conference, University 
of Edinburgh Business School and Chartered Banker Institute conference), news reports (e.g. 
The Telegraph, CoinDesk, CCN, CNBC, TechCrunch, Bloomberg, VentureBeat, Los Angeles 
Times), technology magazines (e.g. Blockchain Magazine, Bitcoin Magazine), technology 
companies’ website (e.g. IBM, Softbank, SAP, Samsung, BP, Maersk), blockchain consultancy 
firms (e.g. Applied Blockchain, Parity Technologies, Intellectsoft Blockchain Lab, Kwôri, 
Cryptonomy) and LinkedIn profiles. The search was conducted in June 2018 and identified 55 
individuals that had their email address available. All were emailed to seek their participation 
in the study. 13 experts responded, and 12 agreed to take part. Semi-structured interviews were 
conducted during July 2018 through phone and lasted between 25 minutes to 1 hour. The 
interviews were recorded and transcribed. 
Table 2: Expert respondents 
Respondent’s 
role 
Company Position 
Intermediaries Small specialized vendor Co-founder and CIO 
Intermediaries Small specialized vendor Advisor 
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IT Expert Association for 
Information Systems 
Academic member 
Researcher Research intensive 
university 
Assistant Professor of 
Management Information 
Systems 
Standardization 
bodies  
Association for 
Information Systems 
President (country chapter) 
Intermediaries Small specialized vendor CEO 
Standardization 
bodies  
Association for 
Information Systems 
Secretary (country chapter) 
Researcher Research intensive 
university  
Professor and Chair of Design 
Informatics  
Consultant Large generic 
technology vendor 
Business development 
consultant 
IT Expert Small specialized vendor Senior support analyst 
Consultant Large generic 
technology vendor 
Business development 
consultant 
Vendor Small specialized vendor CEO 
 
4.3 Vendors database 
A database containing the key blockchain vendors in the healthcare sector and detailing the 
nature of their products was constructed to examine the vendors’ perceptions concerning the 
business value that healthcare organisation may derive from deploying blockchain. Blockchain 
business vendors were identified from the vendors cited in blockchain based news reports (e.g. 
CoinDesk, Mashable, GlobalCoinReport), award winners of key blockchain events (e.g. The 
Blocks, MoneyToken, Smart Dubai Blockchain Challenge), and the list of top blockchain 
vendors in healthcare published by technology related websites and magazines (e.g. Medical 
Futurist, Beckers Hospital Review, CB insights). Four criteria were used to select vendors: (1) 
featured in at least one of these sources (2) offered healthcare products/services based on 
blockchain, (3) had a full-fledged website, and (4) their website contained detailed description 
of the company and its products/services offerings. The search was conducted throughout 
June/July 2018. Table 3 presents the details of the 20 vendors identified, including 17 start-up 
firms and 3 incumbents. 
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All vendors include a dedicated website describing their products and services, customer base, 
advisory board, different departments, contact details, and an explanation of their activities and 
motivation behind their existence in relation to providing blockchain solutions in healthcare.  
Table 3: Details of the selected vendors 
Vendor's name Business 
tvpe 
Technology 
base 
Website 
Zenome Start-up Blockchain https://zenome.io/ 
Dentacoin Start-up Blockchain https://dentacoin.com/ 
MedRec Start-up Blockchain https://medrec.media.mit.edu 
Embleema Start-up Blockchain https://www.embleema.com 
Chanqe Healthcare Start-up Blockchain https://www.chanqehealthcare.com 
Clinisent Start-up Blockchain http://clinisent.com/  
Solve.Care Start-up Blockchain https://solve.care/?l=en 
WELL Incumbent Blockchain https://www.ioinwell.io/ 
Pokitdok Start-up Blockchain https://pokitdok.com 
Nebula Genomics Start-up Blockchain https://www.nebulaqenomics.io/ 
SimplyVital Health Start-up Blockchain https://www.simplvvitalhealth.com 
Outcomes driven 
health 
Start-up Blockchain https://www.odhsolutions.com/ 
Guardtime Incumbent Generic https://auardtime.com/ 
Medicalchain Start-up Blockchain https://medicalchain.com 
HSBlox Start-up Blockchain https://hsblox .com/solutions/ 
FarmaTrust Start-up Blockchain https://farmatrust.io 
FDA-IBM project Incumbent Generic https://www-03.ibm.com/press/us/ 
en/pressrelease/51394.wss 
MediLedger Start-up Blockchain https://www.mediledger.com 
lrvo Start-up Blockchain https://irvo.io/#intro 
Hashed Health Start-up Blockchain https://hashedhealth.com/about/ 
 
4.4  Analysis 
The systematic literature review, interviews and product description data were coded using 
Ojala’s (2016) business model framework (see Table 4). The aim of the analysis was to identify 
the range of interpretations (the rows in table 4) that different categories of actors (the three 
columns in Table 4) develop in relation to the four value components (as per figure 1, and 
included in the first column in Table 4). 
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Table 4. The influence of blockchain on value: categories of value across the four value components and three categories of actors 
Value 
COMPONENTS / 
sub-categories 
Values reported 
related to areas of 
blockchain 
application 
Value interpretations across stakeholders groups 
ACADEMICS 
(studies) 
EXPERTS 
(exemplary quotes) 
VENDORS 
(exemplary quotes) 
V
A
L
U
E
 P
R
O
P
O
S
IT
IO
N
 
Privacy & 
security 
Offering superior privacy (Prakash, 2016) (Liu et 
al., 2017) (Roman-
Belmonte et al., 2018) 
(Liang et al., 2017) (Rifi 
et al., 2017) 
“…With this technology we get an 
opportunity that we can manage our 
digital information in a more secure 
way…” 
“…This platform supports the possibility to 
manage your genomic data while maintaining 
privacy…” (Zenome) 
Offering personalized 
control 
(Prakash, 2016) (Esposito 
et al., 2018) (Engelhardt, 
2017) (Rifi et al., 2017) 
Improving data security 
& integrity 
(Liu et al., 2017) (Weiss 
et al., 2017) (Magyar, 
2017) (Liang et al., 2017) 
Enabling immutable and 
authorized modifications 
to data 
(Esposito et al., 2018) 
(Skiba, 2017) 
Supporting clearer data 
ownership 
(Weiss et al., 2017) 
(Magyar, 2017) (Rifi et 
al., 2017) 
Health data 
management 
Facilitating data 
portability and sharing 
(Prakash, 2016) (Patel, 
2018) (Benchoufi and 
Ravaud, 2017) (Liang et 
al., 2017) (Skiba, 2017) 
“…Basically, the problem that we are 
trying to tackle with Iryo is reducing 
the friction in healthcare data 
exchange…” 
“…Improve health outcomes by gathering 
medical records and sharing with providers 
in a trustworthy manner…” (Embleema) 
Encouraging the 
adoption of structured 
data format 
(Prakash, 2016) 
(Benchoufi and Ravaud, 
2017) (Nugent et al., 
2016) 
Enhancing the 
prevention of 
unauthorized access 
(Patel, 2018) (Nugent et 
al., 2016) (Liang et al., 
2017) (Rifi et al., 2017) 
Streamlining the process 
supporting medication 
prescriptions 
(Zhang et al., 2018) 
(Skiba, 2017) 
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Authentic 
medicine and 
services 
Supporting the reduction 
of counterfeit drug 
(Mackey and Nayyar, 
2017) (Hoy, 2017) 
(Engelhardt, 2017) 
“…If we consider pharmaceuticals 
sector or medicine service, we may 
find that blockchain may integrate 
the effort of anti-counterfeit devices 
to prevent the production of fake 
medicines as well as to enable better 
detection and authentication of 
medicine...” 
“…blockchain technology to securely store 
health records and maintain a single version 
of the truth…” (Medicalchain) 
Improving the provision 
of authenticity in service 
history 
(Weiss et al., 2017) 
(Azaria et al., 2016) 
Accountability 
in healthcare 
Improving the 
auditability of 
transaction/service 
records 
(Liu et al., 2017) “…because the information that we 
derive from blockchain, these are very 
secured and those information are put 
in the chain with much 
accountability…” 
“…blockchain technology establishes 
accountability and transparency in the data 
exchange process…” (FDA-IBM project) 
Enabling the provision of 
personalized health 
service 
(Liu et al., 2017) (Wong 
et al., 2018) 
Facilitating insurance 
claims processing 
(Liu et al., 2017) (Skiba, 
2017) 
Robustness 
Avoiding single point of 
failure 
(Kuo et al., 2017) (Azaria 
et al., 2016) 
“…It can have more robustness and 
participants will not suffer from a 
single point of failure…” 
x 
Service quality 
Improving service 
outcomes and deliver  
x “…an integrated blockchain among 
the parties, from suppliers, 
manufacturers to ultimate customers 
will confirm more secured and timely 
delivery of product without 
compromising the quality…” 
“…enhances the provider, payer and patient 
experience throughout the care continuum, 
driving better outcomes for each healthcare 
stakeholder…” (HSBlox) 
Affordability 
Reducing the cost paid 
by patients for service 
x x “… aims at improving quality of dental care, 
reducing treatment costs…” (Dentacoin) 
Earnings for 
patients 
Enabling the possibility 
to generate Financial 
rewards for patients 
x “…tokenization to empower 
individuals to share data towards 
solving complex and messy 
problems…” 
“ … and ability to make a profit selling access 
to different parts of the genome” (Zenome) 
Social value 
Addressing a social need x “…you can mark the data and it allows 
you to complete transactions, you can 
then associate a whole myriad of 
value to it which can range from 
social, ecological, environmental, 
“… MedRec is the combination of a social 
need with a technological enabler…” 
(MedRec) 
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through medical, through history, 
genetic, biological, religious, faith. So 
yes, absolutely…” 
V
A
L
U
E
 N
E
T
W
O
R
K
 
Data 
accessibility 
Offering the potential for 
universal data access 
(Prakash, 2016) (Liu et 
al., 2017) (Benchoufi and 
Ravaud, 2017) (Roman-
Belmonte et al., 2018) 
“…Data sharing with different third 
parties through integrated blockchain 
will definitely help parties from both 
ends…”  
“…ensures a two-way flow of diagnostic 
information and understanding… wider 
access to diagnostic and any NGS data…” 
(Clinisent) 
Enabling embedded audit 
and confirmation 
(Liu et al., 2017) (Mettler, 
2016) 
Improving the data 
security and integrity 
(Magyar, 2017) 
Facilitating 
interoperability 
(Magyar, 2017) 
Increasing the security of 
data exchange 
(Azaria et al., 2016) 
Avoiding 
intermediation 
Eliminating the need for 
(a trusted) third party 
involvement 
(Prakash, 2016) (Patel, 
2018) (Weiss et al., 2017) 
(Esposito et al., 2018) 
(Till et al., 2017) (Rifi et 
al., 2017) 
“…So, it is automatic. It has no third 
party verification...” 
“…The Zenome project is a decentralized 
blockchain-driven database of 
genomic information… Zenome helps you to 
sell your genetic data without involving big 
companies…” (Zenome) 
Supporting 
decentralization in 
governing exchnages 
(Patel, 2018) (Kuo et al., 
2017) (Roman-Belmonte 
et al., 2018) 
Linking 
network 
partners 
Creating new 
possibilities for closer 
interactions between 
patients, families and 
healthcare stakeholders 
(Prakash, 2016) 
(Rimpoman-Belmonte et 
al., 2018) (Rifi et al., 
2017) 
“…They can very easily 
communicate with each other. So, 
you can have a faster transmission and 
sharing of data…” 
“…our API platform-as-a-service enables you 
to plug directly into over 700 trading 
partners to access real-time transactional 
data at scale…” (Pokitdok) 
Supporting integration 
between the systems of 
diverse healthcare 
providers 
(Engelhardt, 2017) 
Engendering 
trust 
Create new forms of trust 
among partners where 
such trust was absent 
 x “…Yes, in principle, people found 
some instinct to the blockchain or the 
cryptography connected to it that 
engender trust…” 
x 
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V
A
L
U
E
 D
E
L
IV
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Y
 
Transparency 
Improving the tracking of 
pharmaceutical products 
across the supply chain 
(Mackey and Nayyar, 
2017) (Mettler, 2016) 
“…you will absolutely guarantee 
some more transparency about the 
production, supply and delivery of 
drugs…” 
“…increase transparency of the care 
delivery process…” (Pokitdok) 
Improving the 
transparency in research 
& production of drugs 
(Mackey and Nayyar, 
2017) (Borioli and 
Couturier, 2018) (Mettler, 
2016) 
Supporting ways to 
reduce some forms of 
fraud and corruption in 
health financing 
(Till et al., 2017) 
Increasing clarity in 
clinical trials and test 
reports 
(Nugent et al., 2016) 
Proper 
authorization 
Supporting new forms of 
personalized 
authorization for data use 
(Prakash, 2016) (Hoy, 
2017) (Weiss et al., 2017) 
“…The authorization of individual 
data will be facilitated and it will 
result in quick service and timely 
retrieval of data…” 
x 
Speeding up the service 
due to timely retrieval of 
authorized data 
(Prakash, 2016) 
Automation 
Enabling embedded audit 
and compliance reporting 
(Liu et al., 2017) “…I think the automation aspect of 
blockchain can rapidly improve that 
because the medical supply chain has 
lots of different signing walls…” 
“…deploys smart contracts to automate 
multi-party transactions…automates the 
referral administration process…” 
(HSBlox) 
Supporting notification 
of billing, test results and 
medication events 
(Liu et al., 2017) 
Enabling the provision of 
telemedicine services 
(Zhang et al., 2018) 
Redistributing 
resources 
Facilitating the 
redistribution of 
resources to avoid waste 
x “…So, it can be another way of using 
a trusted network to allow the 
redistribution of these resources 
which would mostly be thrown away 
which is inappropriate…” 
x 
V
A
L
U
E
 
C
A
P
T
U
R
E
 
Cost savings 
Reducing errors in 
records and enabling 
automatic data updates 
(Prakash, 2016) (Till et 
al., 2017) (Magyar, 2017) 
“…in long run, when the engagement 
of people reaches certain threshold 
then, of course, it will reduce your 
cost…” 
“…Dynamic medical IT infrastructure 
solutions drive administrative costs down…” 
(Iryo) 
Improving accuracy of 
resource allocation 
(Borioli and Couturier, 
2018) 
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Encouraging the 
introduction of structured 
data thus improving 
replicability of medical 
research 
(Hoy, 2017) (Till et al., 
2017) (Roman-Belmonte 
et al., 2018) 
Eliminating dependence 
on third party for data 
validation 
(Till et al., 2017)  
Reducing cost and risk 
due to better-informed 
decisions by health 
professionals 
(Nugent et al., 2016) 
Automation of health 
insurance claim 
adjustments 
(Zhang et al., 2018) 
Seamless integration 
with providers existing 
infrastructure 
(Azaria et al., 2016) 
Reduced 
auditing 
expenditure 
Improving audit 
compliance 
(Prakash, 2016) (Kuo et 
al., 2017) (Esposito et al., 
2018) (Engelhardt, 2017) 
(Azaria et al., 2016) 
“…Now in blockchain, every piece of 
information entered is verified 
repeatedly, you can significantly 
reduce the auditing costs…” 
“…Compliant with ISO 27001 and relevant 
HIPAA legislation including CMS 2319-
F…” (Clinisent) 
Offering the possibility 
to create a complete and 
consistent medical 
history 
(Kuo et al., 2017) (Zhang 
et al., 2018) (Esposito et 
al., 2018) (Azaria et al., 
2016) 
Preventing fraudulent 
transactions 
(Engelhardt, 2017) 
(Roman-Belmonte et al., 
2018) 
Enhanced 
performance 
and return 
Increasing efficiency (Patel, 2018) (Liu et al., 
2017) (Benchoufi and 
Ravaud, 2017) (Borioli 
and Couturier, 2018) 
(Angraal et al., 2017) 
“…When you will reduce your 
business process time, you will 
increase your efficiency and 
effectiveness…” 
“…orchestrate episode workflows, enable 
visibility into and notification of episodic 
activities, and report required quality 
incentive measures…” (HSBlox) 
Optimizing performance (Borioli and Couturier, 
2018) (Esposito et al., 
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2018) (Angraal et al., 
2017) (Magyar, 2017) 
Facilitating the creation 
of a capital market for 
health data 
(Till et al., 2017) 
Increased 
revenue 
Enhancing return and 
payment certainty 
(Patel, 2018) “…So, I can say that it can ensure 
payment or instalments from every 
ends in every stage. So it can generate 
some more revenue if you ask me…” 
“…A suite of solutions for providers that want 
to better engage with patients, increase 
collections, improve patient financial data, 
and optimize revenue opportunities… 
practices improve revenue cycle efficiency 
and optimize net patient revenue…” 
(Change Healthcare) 
Enhancing brand 
awareness and credibility 
(Borioli and Couturier, 
2018) 
Using smart contracts for 
multilateral and 
outcome-based financing 
(Till et al., 2017) (Roman-
Belmonte et al., 2018) 
Integrating crypto-
currencies to generate 
funding for research 
(Roman-Belmonte et al., 
2018) 
Employment 
generation 
Creating new jobs for 
health service 
professionals 
(Liu et al., 2017) “…it will also increase jobs in new 
horizons. Like monitoring the 
network, that kind of jobs will increase 
more. IT jobs will increase more…” 
x 
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Coding involved a combination of inductive and deductive coding (Miles and Huberman, 1994) 
relying on the data to elicit interpretations that match onto our four categories, rather than fully 
deductive, involving solely the application of a predefined list of codes to the data. Coding was 
done by the first author, following agreement within the research team concerning the approach 
to coding, and was reviewed by the second author during regular discussion sessions to check 
the emerging categories against the data. To assign the codes to sub-categories and sub-
categories to the broad value categories we have relied on the definition of value categories 
and relevant examples from blockchain discussed in Section 2. Thus, we have included all 
codes related to the generation of value for stakeholders, whether at individual (e.g. offering 
privacy and security, improving health data management, increasing service quality) or 
collective (e.g. social value) level. Similarly, we have included as part of value proposition all 
codes related to monetization (e.g. saving costs and enhanced returns). Value delivery and 
value network were occasionally more problematic to distinguish as sometimes changes in the 
nature of activities may be related to changes the nature of relationships between actors (e.g. 
automation of transactions may lead to closer linkages between partners). We thus coded as 
value network all codes that explicitly relate to relationships between the focal firms and others 
(e.g. improving access of data from partners, eliminating the need for a third party to act as an 
intermediary), and coded as value delivery all codes that reflected changes in activities where 
these did not necessarily involved an exchange between the firm and others (e.g. automation 
and transparency of processes) and those that concerned resources (e.g. redistributing 
resources). Where the codes were ambiguous, we resolved them through discussion between 
the two authors, and through examining the wider context in which that code was situated. 
Following coding, the next steps involved distinguishing between categories of expectations 
related to each value dimension to obtain higher level categories, i.e. consider the degree of 
change involved, e.g. improvements or transformation in current value, and the nature of these 
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changes, e.g. increase in volume or quality of interactions (second column in Table 5b). The 
final step involved calculating the relative prevalence of each sub-category within the four 
value dimensions across the three actor groups (columns 2-4 in Table 5a, and 4-6 in Table 5b).  
Table 5A: The prevalence of blockchain’s contribution to the four business value dimensions 
across the three perspectives - overall 
Prevalence across value dimensions 
Systematic 
literature 
review 
Expert 
opinion  
Company 
database 
Average Standard 
deviation 
Value proposition 31% 34% 41% 
35.33% 0.051 
Value network 23% 23% 20% 
22% 0.017 
Value delivery 12% 17% 10% 
13% 0.036 
Value capture 34% 25% 29% 
29.33% 0.045 
Total 100% 100% 100% 
 
 
 
Table 5B: The prevalence of blockchain’s contribution to the four business value dimensions 
across the three perspectives - detailed 
Prevalence across value categories 
Systematic 
literature 
review 
Expert 
opinion  
Company 
database 
Average Standard 
deviation 
V
A
L
U
E
 P
R
O
P
O
S
IT
IO
N
 (
w
h
a
t 
v
a
lu
e 
is
 g
en
er
a
te
d
 f
o
r 
o
th
er
s)
 
Improving 
current value 
proposition 
by 
enhancing 
… 
Privacy and 
security  
38% 15% 36% 
29.67% 0.127 
Health data 
management 
31% 20% 10% 
20.33% 0.105 
Authentic 
medicine and 
services 
15% 15% 6% 
12% 0.051 
Accountability in 
healthcare 
12% 8% 4% 
8% 0.04 
Robustness 4% 2% 0% 
2% 0.02 
Service quality 0% 10% 13% 
7.67% 0.068 
Affordability 0% 0% 4% 
1.33% 0.023 
Creating 
new value 
propositions 
by 
generating… 
Earnings for 
patients  
0% 2% 6% 
2.67% 0.03 
Social value 0% 28% 21% 
16.33% 0.145 
Total 100% 100% 100% 
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Improving 
the ease of 
interaction 
by … 
Facilitating data 
accessibility 
37% 33% 39% 
36.33% 0.03 
Changing 
the volume 
of 
interaction 
by … 
Avoiding 
intermediation 
42% 33% 22% 
32.33% 0.1 
Changing 
the quality 
of 
interactions 
by … 
Linking network 
partners 
21% 15% 39% 
25% 0.124 
Engendering trust 0% 19% 0% 
6.33% 0.109 
Total 100% 100% 100% 
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p
ro
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ss
es
) 
Improving 
current 
processes by 
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Cost savings 32% 38% 33% 
34.33% 0.032 
Lower auditing 
expenditure 
21% 17% 21% 
19.67% 0.023 
Performance and 
return 
29% 7% 36% 
24% 0.151 
Revenue 14% 21% 10% 
15% 0.055 
Creating 
new forms 
of value  
capture by 
generating 
… 
New employment 4% 17% 0% 
7% 0.088 
Total 100% 100% 100% 
 
 
We calculated the relative prevalence of value dimensions by calculating the percentage of 
mentions of a value dimension relative to the mentions of all the value dimensions within each 
stakeholder study. For example, within the expert study, “value proposition” was coded 40 
times across all expert interviews, and all four value categories were coded in total 116 times. 
Thus the relative prevalence of “value position” was 34% for the expert study (40/116) (see 
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Appendix 8). The prevalence of value sub-categories within each value dimension was 
measured in a similar way by considering, in percentages, its relative number of mentions to 
the total number of mentions of all of the value sub-categories within that particular value 
dimension (see Appendix 7-9). We also tested all 26 individual prevalence scores to examine 
if they are significantly different from the mean with distribution of simulated scores and one-
sample t-test at 95% confidence level. These findings are then discussed across the three 
perspectives in the next section. 
5. Findings 
This study explores how different healthcare actors make sense of blockchain and understand 
its value, while its key features and functionalities are still being developed. There are two 
sides to this goal: understanding the value of blockchain as perceived by members of the 
blockchain community, and clarifying the degree of coherence in how this value is understood 
across the blockchain healthcare community. 
5.1 The value of blockchain in healthcare 
Traditional perspectives considering the business value of new IT such as resource-based view 
or business process perspective emphasise the organisation as the key beneficiary of value. The 
business model framework instead examines the value created both for the user organisation, 
in this case, healthcare providers, and for their stakeholders, e.g. patients. The application of 
Ojala’s (2016) four component framework allows the analysis to disentangle the ways in which 
the use of blockchain creates value by shaping both the value generated for the user 
organisation and other relevant stakeholders (value capture and creation components), and how 
this value is generated (value delivery and network components) (see figure 3).  
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How does technology use affects 
HOW IS THIS VALUE GENERATED?
(system of organisational 
activities)
How does technology use affects 
WHAT VALUE IS GENERATED?
(outcome of organisational 
activities)
THE VALUE OF A NEW 
TECHNOLOGY DEPLOYMENT
the value captured by 
the organisation?
the interactions 
between the 
organisation and its 
partners?
the business 
processes (activities 
and resources)?
the value created for 
stakeholders?
Improving the current value by enhancing 
the features & quality of service 
Creating new forms of value, e.g. financial 
and social value
Improving the ease of interaction, e.g. data 
accessibility
Changing the volume of interaction, e.g. 
disintermediation
Changing the quality of interaction, e.g. 
collaboration and trust
Improving current processes, e.g. in terms of 
transparency, authorization & automation
Changing existing processes, e.g. new ways 
of distributing resources
Improving current value capture by raising  
performance (lower costs, higher revenue)
Creating new forms of value capture, e.g. 
generating employment
 
Figure 3. The value of a new technology deployment 
5.1.1 Value proposition 
In line with existing research, findings indicate that blockchain is expected to improve the 
value proposition of healthcare organisations primarily through enhancing privacy and 
security, offering more efficient management of health data, and to a lesser extent, enhancing 
accountability, thus offering better services to patients. These perceptions are shared across our 
community of actors (see Tables 5). Enhanced privacy and security is achieved as the use of 
blockchain offers customers the ability to enhance their control over their own medical records, 
and improve the privacy and data security, integrity and immutability, as well as the ability to 
identify data sharing and ownership by digital signatures. Better health data management is 
achieved through reducing friction in health data exchange, improving data tracking and 
verification, supporting the management of electronic health record system, enabling the 
reproducibility of clinical trials and disease reporting, and connecting multiple sources of data. 
All actors also mention blockchain’s ability to enable authentic medicine and health services 
by reducing fraudulent practices through ensuring data immutability and provenance. 
Authenticity is highlighted primarily in the context of low-income countries where the problem 
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of counterfeit medicine is acute. All actors also mention blockchain improves accountability, 
as the technology can support accurate insurance claim processing and auditable treatment and 
healthcare services, and more generally to facilitate the delivery of more accountable health 
services. Finally, while existing research and experts find that blockchain may improve 
robustness in data exchange as it can produce multiple data copies, and relies on many entities 
thus reducing the risk of failure, this view is not shared by vendors. 
The findings also highlight several ways in which blockchain alters the value proposition, 
which are not recognised in existing research. Both vendors and experts find that blockchain 
improves current value proposition through (1) improving the quality of healthcare service 
provision through enabling speedy delivery of healthcare products and services, and offers new 
forms of value proposition by (2) offering the patients  the ability to earn money through 
providing a platform that enables patients to sell access to their health data to healthcare 
researcher organisations, and by (3) enabling the delivery of social value through reducing 
fraud, encourage trust and morality, and supporting honesty and ethical behaviour in health 
data exchanges. Vendors are alone in suggesting that blockchain may improve the affordability 
of healthcare services through improving patients’ medication adherence and thus ultimately 
lowering the costs of medication for patients.   
5.1.2 Value network 
In line with existing research, our findings show a wide agreement within the healthcare 
community concerning blockchain’s impact on transforming the healthcare organisations’ 
networks in three ways: improving the ease, changing the volume and altering the quality of 
interactions within the network. Blockchain is widely perceived to ease interactions amongst 
healthcare actors by improving data accessibility through enabling universal data access, 
embedded audit and confirmation, interoperability, and secure data exchange. Similarly, all 
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actors recognized blockchain’s ability to alter the volume of interactions by reducing 
intermediation. Less intermediation is linked to the decentralized and independent nature of 
blockchain, which is perceived to eliminate the need for trusted mediators to verify 
accurateness in exchanges amongst healthcare network partners. Less intermediation is widely 
expected to lead to cheaper, faster and more reliable health services, and leaner supply chain, 
and to empower patients to manage their own health data. To a lesser extent, there is agreement 
across the community that blockchain improves the quality of interactions by establishing 
stronger links among patients, families, health professionals, insurance organization and other 
healthcare stakeholders, while also integrating distinct health service providers through sharing 
health records data, and through facilitating the integration of telemedicine and biometric 
devices such as smartwatches and mobile phones in the healthcare system.  
The findings also highlight a new way through which blockchain changes the quality of 
interactions within the healthcare providers’ value network, although this view is not shared 
across the community. Experts alone argue that blockchain improves trust amonst nework 
partners through enabling faster data transmission and a decentralized database system, which 
is critically especially in contexts where corruption is high and trust is lacking. Such expected 
benefits were however not supported by existing research, nor were they claimed by vendors.  
5.1.3 Value delivery 
In line with existing research, creating value through value delivery was the least emphasised 
dimension across all three actors. By and large, blockchain is perceived to improve existing 
organisational processes by enabling healthcare actors to track every stage of the 
pharmaceutical supply chain thus enhancing transparency in health service delivery. Better 
transparency is associated with the reduction in fraud and corruption in healthcare financing, 
the ability to demonstrate provenance of digital data, and better clarity in clinical trials and test 
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reports (existing research and vendors). Experts emphasise the benefits of transparency for 
low-income countries with corrupt administration where transparency reduces the production 
of counterfeit drugs, while vendors highlight the benefits of transparency in facilitating the use 
of patients’ data for medical research by healthcare providers. To a less extent, all actors also 
empahsise the ability of blockchain to automate a wide range of health service processes which 
is seen to speed up and simplify health service delivery.  
There is less consistency between actors’ expectations related to blockchain’s ability to 
facilitate patients to authorise the use of their health data during the delivery of health services. 
Enhanced authorisation of data use is perceived as a benefit only in existing research and expert 
interviewing, but does not come across in vendor data. 
The findings also identify a new way through which blockchain is seen to change existing 
processes, through supporting the redistribution of resources enabling actors to minimizing 
waste in healthcare resource (experts). For example, a blockchain based medicine record where 
users could post the drugs they have and do not need would enable actors to re-think the way 
in which health resources are redistributed among users of healthcare products, not only 
reducing medical wastage but also enabling new types of processes to enable users to access 
medicine. However, this view is not shared across the community. 
5.1.4 Value capture 
Our analysis finds that blockchain is widely seen across the community as improving the 
value that the organisation captures back through enabling cost savings, primarily through 
reducing auditing costs, increasing the performance and revenue of healthcare organisations, 
and enabling the creation of new forms of value capture for the organisation through 
generating additional sources of employment. These expectations are shared across the 
community, with the exception of the latter, which is emphasised mostly by experts. 
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Blockchain is primarily expected to reduce healthcare providers’ costs through the changes it 
brings in enhancing the value network (e.g. enabling better integration of diverse sources of 
data across the healthcare network) and delivery (e.g. enabling automation in supply chain, 
reducing fraud and data errors, improving accuracy of resource allocation). Most significantly, 
all actors emphasise blockchain contribution to reducing healthcare providers’ auditing 
expenditure by enabling complete and consistent medical history, auditable transactions, and 
preventing fraudulent transactions through secure and time-stamped medical records. These 
perceptions are shared across the community. In contrast, experts alone mention that 
blockchain allows healthcare organisation to raise funding at lower costs through initial coin 
offerings, and mention the reduction in legal expenses associated with compliance with data 
protection and privacy rights regulations. 
To a much lesser extent, blockchain is also perceived by the entire community to increase 
revenues by ensuring certainty of payments, enhancing brand awareness, creating trust which 
enhances customer loyalty, and by using smart contracts and crypto-currencies to generate 
funding. Blockchain is also expected to enhance organizational performance through 
increasing efficiency, optimizing performance, reducing business process time and maximizing 
resource utilization. Vendors alone mention that using blockchain to enhance value delivery 
(e.g. through improving doctors and researchers’ access to patients’ data; preventing 
duplication of process and providing real-time data sharing) boosts organisational performance 
(e.g. improves doctors’ ability to conduct research but reduces data management costs; reduces 
time in healthcare delivery processes while improving diagnosis). While the performance-
enhancing dimension is emphasised by vendors, it is downplayed by experts, who highlight 
instead the effects of reducing cost and increasing revenues.   
Finally, experts, and to a much lower extent existing research, highlight that blockchain 
deployments enable organisations to capture new forms of social value through creating new 
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jobs for health service professionals in the areas of blockchain’s deployment, maintenance and 
quality assessment of automated health services. 
5.2 Blockchain value: a multi-stakeholder approach 
Existing research suggests that the expectations that a technology community forms concerning 
the organisational application and value of an emerging technology are critical in explaining 
its patterns of diffusion, at least in its early stages (Swanson and Ramiller, 1997). The findings 
reveal several differences in the emphasis stakeholders place on the categories of value within 
the four business model components, focusing on either incremental or transformational 
changes in value creation and capture. These differences were identified by examining the 
standard deviation between the relative percentages across the three actors (see Table 5). Thus, 
the higher the standard deviation, the higher the degree of incongruency between the actors’ 
expectations. To check the results based on standard deviation, all individual prevalence scores 
are tested to examine if they fall within the desired range (95% confidence interval) in the 
distribution of simulated scores, prepared with the observed level of randomness. To reconfirm 
the finding, the individual prevalence scores are tested to examine if they are significantly 
different from the mean with a one-sample t-test at 95% confidence level. 
Overall, the findings indicate a high degree of coherence amongst the community expectations 
regarding blockchain application in healthcare (the degree of incongruency varied between 
0.017 and a relatively low 0.1522, all the observed scores were within the 95% confidence 
interval, and the one sample t-test found that all the prevalence scores are not significantly 
different from the average score3), contrary to research examining the diffusion of other new 
technologies in healthcare (e.g. telehealth, (Greenhalgh et al., 2012); IT programme, (Currie 
                                                 
2 The highest standard deviation possible in our case (for 0%,0%,100%) is 0.471, hence why 0.152 is considered 
still relatively low.  
3 The simulated distributions and t-test results are not reported due to length limitations. 
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and Guah, 2007)). The expectations of the three categories of stakeholders studied here 
converge on highlighting that the key sources of value are concentrated around value 
proposition and capture (whose average together counts for 64.66% of the perceptions of 
value), followed by value network (average of 22%), with value delivery being the least 
emphasized value creation mechanism (13% in average). Moreover, Tables 5 show that the 
most common expectations is that blockchain will improve existing forms of value, and the 
current approach to generate such value, rather than drastically transforming them. 
Expectations of value transformation represent only 19% for value proposition and 7% for 
value capture. Similarly, changes to current processes represent only 1.67% of expectations 
concerning value delivery. The only situation where expectations of transformational impact 
are predominant is in the case of value network, where changes in the volume and quality of 
interactions represent 63.67%. The deployment of blockchain is thus expected to generate 
value mostly by improving healthcare organizations’ current value proposition through 
enhancing privacy and security and improving health data management; improving and 
transforming their value networks through enhancing data accessibility and reducing the need 
for intermediation; enhancing value delivery through improving transparency; and supporting 
existing value capture mechanisms through cost savings and reducing auditing expenditure. 
The overlap between the expectations, both at the level of the overall value components (the 
emphasis on value proposition and capture) and at the level of the value categories within these 
components (for example around transparency and cost savings) suggest that the community 
is developing a consistent message to attract blockchain users. Such convergence suggests that 
the community’s vision concerning the application of the technology is coherently understood, 
with similar interpretations of how blockchain can create value for adopting healthcare 
organizations and their customers. Such coherence is critical to ensure the technology gains 
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cognitive legitimacy within the community (Wang and Swanson, 2007) increasing its chances 
of successful diffusion (Kaganer et al., 2010).  
While experts may be the most optimistic, and vendors emphasize the most immediate aspects 
of value, most of their expectations are substantiated by existing academic research suggesting 
a narrow gulf between discourse and reality. This broad fit between rhetoric and practice (as 
demonstrated by findings of current research on blockchain deployments) increases the 
credibility of vendors and experts’ claims, thus legitimizing the technology and increasing the 
chances of successful diffusion (Kaganer et al., 2010). The ability to articulate a clear and 
credible message about what the value of the technology is for its adopters is likely to enhance 
the development and maintenance of a consistent organizing vision within and beyond its 
community, positively affecting its adoption and diffusion (Currie, 2004). 
Nevertheless, our findings also identified variations in value expectations across the 
community. Existing academic research highlights fewer value categories across all four value 
components. Some of the areas of value proposition such as earnings for patients, service 
quality, affordability and social value remain entirely unexplored in existing research. Among 
the other value components, there is no evidence that blockchain engenders trust, redistributes 
resources, and generates employment within the healthcare sector. A reason behind the lack of 
academic focus in these areas could be that blockchain is still in an early stage, with research 
on healthcare applications starting from 2016 only. In addition, most published research on 
blockchain in healthcare are pilot studies, and thus focus on value arising from small-scale 
implementation. Another reason is that while experts and vendors emphasise the promissory 
aspects of blockchain to legitimise their investments in blockchain (van Lende, 2012), existing 
studies tend to focus on actual deployments, where the focus is on realised benefits, rather than 
potential outcomes.  
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Blockchain vendors’ expectations stress privacy and security, social value, data accessibility, 
linking network partners, cost saving and enhanced performance and return. Generally, vendors 
seem to attempt to advertise aspects of blockchain value that they perceive is an important 
criterion for their clients, and/or on which their business model offers a direct and significant 
impact. For example, vendors put the highest emphasis (41%) on describing the value 
proposition and value capture (29%), thus suggesting that they are mostly interested in 
highlighting their new value offerings and how these offerings translate into saved costs or 
enhanced income. Lower costs and higher income represent direct benefits associated with the 
use of IT (Bunduchi and Smart, 2010) and as such are more visible to the clients. Vendors have 
placed comparatively less emphasis on the value network (20%) and value delivery (10%) 
dimension possibly because these benefits are indirect, involving improvements in process 
efficiencies or strategic changes in existing network relationships (Bunduchi and Smart, 2010), 
and are thus less visible to end users. In addition, often vendors take advantage of (and often 
contribute to) the market hype by aligning their offerings with what they perceive their 
customers need, thus seeking pragmatic and cognitive legitimacy for their offering (Kaganer 
et al., 2010). For example, about half of the vendors promised that their blockchain solutions 
will deliver social value which matches current trends towards businesses delivering social 
value, especially so in the healthcare space.  
Overall, experts supplied the largest number of value categories across all categories, while 
also providing the most balanced view (the difference between their top and bottom category 
varies between 34%-17% comparing with 34%-12% for academic research and 41%-10% for 
vendors). Experts also identified a range of new value categories including creating trust, 
engendering employment opportunities, and redistributing healthcare resources which were 
supported neither by vendors’ nor by current research. Why are experts the most enthusiastic 
and optimistic about blockchain’s value? Experts often act as founders, advisors, analysts, chief 
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executive officer, chief information officer, researcher and member of the standardization 
bodies related to blockchain technology, and thus have not only direct technical expertise but 
also direct interest in the diffusion of blockchain. It is thus not entirely unexpected that experts 
were the most positive in their value expectations. Variations in expectations have been 
attributed in previous research to differences in actors’ interests (Currie, 2004), as well as to 
their experience with the technology and context of deployment (Orlikowski and Gash, 1994). 
Nevertheless, several experts did highlight the trade-offs involved in blockchainand expressed 
concerns about the blockchain’s capability to deliver its promises.   
6. Discussions  
We set out this study with two research questions (1) understanding the value the blockchain 
creates in healthcare and (2) understanding the degree of coherence that the healthcare 
community forms around this new technology. Regarding the first research question, our study 
finds that blockchain delivers value mostly through enhancing, and to a lesser extent through 
transforming, all four components of the business model. The most important avenues for 
business value generation through blockchain include improvements in current value 
proposition (primarily in the form of enhanced privacy and security and health data 
management), and value capture (primarily through facilitating cost savings and reducing 
auditing expenditure). The contributions of blockchain to value network and value delivery 
were much less emphasised. For value network, value arose through improving data 
accessibility and avoiding intermediation, while for value delivery through improving 
transparency in supply chain. Overall, expectations across the community emphasise 
incremental improvements in value, rather than the radical transformation suggested in some 
recent research (e.g. Allen et al., 2020). Regarding the second research question, our analysis 
points to a high degree of coherence amongst the blockchain community members concerning 
their expectations for value generation, but also identifies a few areas of divergence. In the 
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context of blockchain’s value capabilities in healthcare, the biggest disagreements were noticed 
around the areas of social value (for value proposition), engendering trust (for value network), 
automation (for value delivery), and employment generation (for value capture). Most of these 
areas of disagreement concern areas blockchain is expected to radically transform existing 
value, and thus where the level of uncertainty is higher, such as creating new forms of value 
creation and capture and changing the quality of interactions.  
The contributions of this study to existing research are twofold. First, the study contributes to 
research on the value of IT in organisations. Despite the insight that expectations and 
interpretations matter as much as the outcomes of technology deployment in shaping its 
adoption, use and diffusion (Kaganer et al., 2010, Swanson and Ramiller, 1997, Davidson and 
Pai, 2004, Orlikowski and Gash, 1994), and the realisation that digital technology requires 
different perspectives in examining its contribution to value creation (Amit and Zott, 2001, 
Bharadwaj et al., 2013, Yoo et al., 2012), research on the business value of IT continues to take 
an outcome-based perspective and draw from traditional perspectives to frame the investigation 
of value (Schryen, 2013). Drawing broadly from the technology frame (Davidson, 2002) and 
the aligned organizing  vision (Swanson and Ramiller, 1997) perspectives, which considers the 
business value of IT as the result of actors’ efforts to make sense of new technology, the study 
applies Ojala’s (2016) business model framework to examine how different actors understand 
the value of blockchain within a particular sector. Our approach to examine the value of 
technology through the combined lens of the business model and organizing vision approaches 
has two key advantages over traditional perspectives to consider the business value. On one 
hand, applying a business model lens allowed the research to identify of a range of value 
dimensions that were ignored in previous research, particularly around non-economic and 
network value outcomes. For example, a key finding concerns the need to expand the 
understanding of blockchain’s business value beyond economic dimensions to incorporate 
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social aspects of value associated with changes in the value proposition. Similarly, the analysis 
reveals the potential of blockchain to engender trust between firms’ stakeholders and to 
redistribute resources across the network in a way that improves stakeholders’ ability to 
exchange value. Capturing such social and network value outcomes of technology deployment 
is difficult when relying on traditional economic and firm centric approaches to examine value 
which dominate current IT value  research (Bharadwaj et al., 2013, Kohli and Grover, 2008, 
Yoo et al., 2012), such as the resource based view (Mata et al., 1995) or the strategic alignment 
approach (Henderson and Venkatraman, 1999).  
On the other hand, using the organising vision lens highlighted the need to consider a 
stakeholder-based approach for analysing business value especially in the context of emerging 
new technologies. Emerging new technologies lack a history of successful implementation, 
meaning that actors form expectations of value based on its potential, rather than on evidence 
of its implementation within user organisations (Borup et al., 2006). Moreover, multiple 
expectations of value associated with a new technology often emerge within its community and 
have been shown to shape its adoption and diffusion (Kaganer et al., 2010, Swanson and 
Ramiller, 1997). While research drawing from the sociology of expectations (Borup et al., 
2006; van Lende, 2012), technology frames (Olesen, 2014) and organising vision (e.g. 
Greenhalgh et al., 2012) frameworks has widely acknowledged the importance that multiple 
value expectations play in shaping the trajectory of a new technology, there has been little 
effort in IT business value research to examine these value expectations. Instead, the focus 
remains solidly on examining the (expectations of) value from the perspective of the focal firm 
(Kohli and Grover, 2008; Melville et al., 2004). The success of a new technology is however 
rarely solely the preserve of adopting firms, instead relying on involvement of a wider 
community of loosely connected actors ranging from vendors and IT consultancy firms to 
research units and regulatory organisations (Currie, 2004; Wang and Swanson, 2007). Our 
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study shows that value expectations do vary between different stakeholders involved in the 
adoption of a new technology, and in doing so has also identified a range of new value 
outcomes that were ignored in existing research, where the analysis focused exclusively on the 
perspective of user organisations. Our analysis thus demonstrates the need to take a stakeholder 
approach when examining the value of a new technology. 
Second, the study contributes to research on blockchain in general, and in healthcare in 
particular. While existing blockchain research has been concerned with examining the value of 
the technology in a variety of contexts (Tapscott and Tapscott, 2016), there has been little effort 
to systematically explore the nature of these value outcomes, nor to consider whether such 
value claims vary across sectors, actors or specific applications. Current research either focuses 
on implementations in specific sectors (e.g. Kewell et al., 2017; Kim and Laskowski, 2018), 
or lumps together different applications, actors and sometimes sectors in their analysis (e.g. 
Elsden et al., 2018; Underwood, 2016). Moreover, the scarcity of large-scale implementations 
of blockchain (Hughes et al., 2019) means that there is limited understanding of the actual 
value of blockchain (Pan et al., 2020). Our approach offers a framework to disentangle the 
blockchain’s value outcomes sub-categories for each of the four value components. Employing 
this value outcomes framework both sensitises researchers to consider both incremental and 
radical changes, to include under-explored value outcomes (such as value delivery, or non-
economic outcomes), and enables systematic analyses of the value potential of blockchain 
across sectors and applications. Moreover, we show that value expectations around blockchain 
vary across actors, and more so for some value components than for others (e.g. value 
proposition). This finding highlights the need for blockchain research to take a stakeholder 
approach when examining value claims. 
Furthermore, most current research on blockchain in healthcare focuses on the technical aspects 
of blockchain, e.g. Patel (2019), rather than the value creation potential of the technology. The 
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few studies that highlight the benefits of blockchain do so in a descriptive manner, relying 
mostly on single case studies, e.g. Zhang et al. (2018), and often pilot implementations, e.g. 
Azaria et al. (2016). Much of existing studies also fall short in methodological rigour. This 
study thus brings two contributions to current healthcare blockchain research. First, it provides 
a robust and comprehensive evaluation of the value of blockchain by combining the perspective 
of three key members of blockchain community: academics, vendors and technology experts. 
Second, it points to a number of avenues through which blockchain creates value which are 
currently ignored, both for user organisations, for example through enhancing trust and 
strengthening linkages across the value network, and their patients, such as financial and social 
benefits. 
For practitioners, understanding how blockchain may alter what value organisations generate, 
and how such value is generated can help them to better assess the business case for investing 
in blockchain. Recent research advises that practitioners should follow a pragmatic approach 
to assess the benefits of blockchain (Hughes et al., 2019), and suggest they use the business 
model to examine the implications of blockchain and guide their decision to implement or not 
blockchain (Tonniseen and Teuteberg, 2020). We take these suggestions forward, and develop 
a structured framework (see Table 5b; figure 3) that delineates different sub-categories of 
blockchain value. This blockchain value framework can inform IT managers in user 
organisations when examining the business case for investment in blockchain, as well as a 
providing a checklist to monitor the realised outcomes from blockchain. We also find that 
despite the current emphasis on transformative outcomes, most current expectations focus on 
incremental improvements. We thus recommend that in implementing blockchain, focusing 
first on clarifying incremental changes in value would be more likely to match existing 
expectations in the community. We also highlight that different groups of actors have different 
expectations. To make sense of the potential of blockchain, it is important to consider the 
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expectations concerning the benefits of blockchain not only of practitioners (Wang et al., 
2019), but also of other actors that are directly involved in it is implementation (e.g. vendors 
as well as experts such as consultants that the organisation may employ). Whether for vendors 
seeking to convince users to implement blockchain, or for users seeking to decide whether 
blockchain creates value for their organisation, our findings suggest the need to include a wider 
range of actors in their evaluations of the technology value, and a more diverse range of value 
categories, particularly in relation to network and non-economic outcomes.  
7. Conclusion 
We set out to examine the value of blockchain in healthcare through the combined lens of the 
business model and organizing vision approaches. Based on the four business model value 
components, we build a blockchain value framework that identifies different categories of 
value outcomes associated with the deployment of blockchain. The analysis identifies a range 
of value outcomes ignored in existing research, and finds a high degree of congruence in the 
value expectations across the community. We bring several contributions both to IT value 
research, by demonstrating the value of the combined framework, and to blockchain research 
in healthcare, by developing a systematic and rigorous approach to examine the value of 
blockchain across different contexts. 
No study is without limitations, and this research is no exception. The key downside is the 
inclusion of only three sets of actors: experts, vendors and academic research. Including 
healthcare providers and patients, as well as other stakeholders in the value chain (e.g. 
healthcare research, regulators), rather than relying on experts and academic research to relay 
their views would have strengthened the analysis. At the time of our study, blockchain diffusion 
was still in its nascent stages, and there was a very limited number of cases of real world 
blockchain implementations beyond small-scale, pilot studies (Du et al., 2019; Hughes et al., 
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2019). Moreover, the complexity of the technology makes it more difficult to understand to the 
non-expert audience comparing with other technological innovations in this sector (e.g. 
robotics or telemedicine) where the potential applications are easier to conceive. Consequently, 
healthcare providers are not included as a group at this stage due to their limited exposure to 
blockchain. Considering the early stage of blockchain deployment as well as the complexity of 
the technology, we have thus only selected stakeholders that had direct experience of the 
technology, and/or the expertise necessary to provide an informed view. As the technology 
becomes more accepted, the number of real world applications increase, the role of other 
stakeholders such as healthcare providers, patients and regulators increase in shaping shape the 
future diffusion pattern. 
There are a few avenues for further research. First, this study was based on mostly cross-
sectional data, though the systematic literature review includes some findings from past periods 
(but short in span). A longitudinal study would provide a more comprehensive view of changes 
in the interpretations of blockchain’s value over time, pinpointing the evolutions in the 
interpretations of business value across the community across a larger timeframe. Besides the 
business model-based research framework, applying multiple lenses to examine blockchain’s 
business value, such as business process view, resource-based view, strategic alignment-based 
view would enable the research to establish the overlaps and differences afforded by these 
theoretical lenses, and consider which work best for which purposes.  
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